OHI
Omega Healthcare Investors Inc
$48.29
-0.15 (-0.31%)
At close · Jul 14
Market Cap
$14.28B
Shares
297,802,000
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.19B
+13.2%
FY2025
Net Income
$590.19M
+45.2%
FY2025
Operating Margin
59.4%
+3pp
FY2019
Diluted EPS
$1.94
+25.2%
FY2025
Operating Cash Flow
$878.55M
+17.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.24B | $1.19B | $1.05B | $949.74M | $878.24M | $1.06B | $892.38M | $928.83M | $881.68M | $908.39M | $900.83M | $743.62M | $504.79M | $418.71M | $350.46M | $292.2M | $258.32M | $197.44M | $193.76M | |
| $1.04B | $1B | $887.91M | $826.39M | $751.23M | $923.68M | $753.43M | $842K | $767.34M | $775.18M | $743.89M | $605.99M | $388.44M | $375.14M | $314.59M | $273.52M | $232.77M | $164.47M | $155.77M | |
| $98.1M | $104.14M | $88M | $81.5M | $69.4M | $64.63M | $59.89M | $57.87M | $63.51M | $47.68M | $45.87M | $38.57M | $25.89M | $21.59M | $21.33M | $19.43M | $15.05M | $11.74M | $11.7M | |
| — | — | — | — | — | — | — | — | — | $11.9M | $14M | $13.8M | $5M | $5.1M | — | — | — | — | — | |
| $329.51M | $325.25M | $304.65M | $319.68M | $332.41M | $342.01M | $329.92M | $301.68M | $281.28M | $287.59M | $267.06M | $210.7M | $123.26M | $128.65M | $112.98M | $100.34M | $84.62M | — | — | |
| $21.77M | $22.61M | $23.83M | $91.94M | $38.45M | $44.66M | $75.97M | $48.94M | $35.01M | $99.07M | $58.73M | $17.68M | $3.66M | $415K | $272K | $26.34M | $155K | $159K | $5.58M | |
| $679.85M | $688.02M | $648.89M | $793.58M | $799.67M | $776.99M | $734.95M | $641.5M | $610.29M | $647.12M | $391.08M | $332.35M | $159.48M | $153.04M | $135.49M | $154.41M | $109.38M | $81.55M | $89.02M | |
| $380.67M | — | — | — | — | — | — | $551.75M | $497.59M | $315.17M | $559.95M | $411.27M | $345.31M | $265.68M | $214.97M | $137.8M | $148.94M | $115.89M | $104.74M | |
| — | — | — | — | — | — | — | 59.4% | 56.44% | 34.7% | 62.16% | 55.31% | 68.41% | 63.45% | 61.34% | 47.16% | 57.66% | 58.69% | 54.05% | |
| $708.46M | — | — | — | — | — | — | $853.43M | $778.87M | $602.77M | $827.02M | $621.97M | $468.57M | $394.33M | $327.95M | $238.13M | $233.56M | — | — | |
| $192.55M | — | — | — | — | — | — | — | $192.46M | $188.76M | $164.1M | $147.38M | $119.37M | $100.38M | $95.53M | $81.15M | $67.34M | $36.08M | $37.75M | |
| $848K | — | — | — | — | — | — | — | — | $267K | $173K | $285K | $44K | $41K | $29K | $40K | $105K | $21K | $240K | |
| $113.33M | $122.36M | $18.25M | $99.47M | $357.57M | $130.27M | $4.89M | $56.51M | -$201.08M | -$209.25M | -$175.62M | -$183.1M | -$126.83M | -$92.01M | -$106.07M | -$86.86M | -$90.5M | -$34.53M | -$38.98M | |
| — | — | — | — | — | — | — | — | $11.5M | — | — | $6.4M | $2.9M | $1.2M | — | — | — | — | — | |
| $2.47M | -$218K | $7.92M | -$582K | $7.26M | $16.06M | $6.14M | $10.95M | $381K | $2.24M | $439K | — | — | — | — | — | — | — | — | |
| $669.54M | $624.22M | $428.66M | $255.05M | $436.14M | $416.08M | $162.33M | $343.84M | $296.51M | $105.92M | $384.33M | $234.53M | $221.35M | $172.52M | — | — | $58.44M | $82.11M | $77.62M | |
| $16.24M | $14.75M | $10.86M | $6.26M | $4.56M | $3.84M | $4.93M | $2.84M | $3.01M | $3.25M | $1.41M | $1.21M | — | — | — | — | $0 | $0 | -$72K | |
| $632.2M | $590.19M | $406.33M | $242.18M | $438.84M | $428.3M | $163.55M | $351.95M | $293.88M | $104.91M | $383.37M | $233.32M | $221.35M | $172.52M | $120.7M | $52.61M | $58.44M | $82.11M | $78.14M | |
| — | 49.59% | 38.65% | 25.5% | 49.97% | 40.3% | 18.33% | 37.89% | 33.33% | 11.55% | 42.56% | 31.38% | 43.85% | 41.2% | 34.44% | 18% | 22.62% | 41.59% | 40.33% | |
| $23.78M | $19.28M | $11.48M | $6.62M | $11.91M | $11.56M | $4.22M | $10.82M | $12.31M | $4.49M | $16.95M | $8.79M | — | — | — | — | — | — | — | |
| $615.87M | $572.03M | $406.33M | $242.18M | $426.93M | $416.74M | $159.33M | $341.12M | $281.58M | $100.42M | $366.42M | $224.52M | $221.35M | $172.52M | $120.7M | $47.46M | $49.35M | $73.03M | $70.55M | |
| $643.64M | $646.49M | $399.72M | $251.19M | $449.45M | $427.31M | $186.42M | $342.92M | $270.08M | $124.1M | $321.3M | $215.81M | $221.35M | $172.52M | — | — | $58.44M | $82.11M | $78.14M | |
| USD/shares | — | $1.96 | $1.57 | $1.01 | $1.81 | $1.76 | $0.70 | $1.60 | $1.41 | $0.51 | $1.91 | $1.30 | $1.75 | $1.47 | $1.12 | $0.46 | $0.52 | $0.87 | $0.94 |
| USD/shares | — | $1.94G | $1.55 | $1.00 | $1.80 | $1.75 | $0.70 | $1.58 | $1.40 | $0.51 | $1.90 | $1.29 | $1.74 | $1.46 | $1.12 | $0.46 | $0.52 | $0.87 | $0.94 |
| shares | — | 291.65M | 258.12M | 240.49M | 236.26M | 236.93M | 227.74M | 213.4M | 200.28M | 197.74M | 191.78M | 172.24M | 126.55M | 117.26K | 107.59M | 102.12M | 94.06M | 83.56M | 75.13M |
| shares | — | 304.95M | 270.45M | 250.45M | 244.29M | 244.34M | 235.1M | 222.13M | 209.71M | 206.79M | 201.64M | 180.51M | 127.29M | 118.1K | 108.01M | 102.18M | 94.24M | 83.65M | 75.21M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $145.2M in buybacks, $7.57B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
23.05×
REIT - Healthcare Facilities median 33.08×
Valuation over time computed as of each quarter's filing date
Key facts
CIK
888491
CUSIP
681936100
13F (30d)
81 filings
62 filers
Visit website
Investor relations